Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 149

1.

Comparison of self-controlled designs for evaluating outcomes of drug-drug interactions: simulation study.

Bykov K, Franklin JM, Li H, Gagne JJ.

Epidemiology. 2019 Aug 12. doi: 10.1097/EDE.0000000000001087. [Epub ahead of print]

PMID:
31430267
2.

Association of Preoperative Opioid Use With Mortality and Short-term Safety Outcomes After Total Knee Replacement.

Kim SC, Jin Y, Lee YC, Lii J, Franklin PD, Solomon DH, Franklin JM, Katz JN, Desai RJ.

JAMA Netw Open. 2019 Jul 3;2(7):e198061. doi: 10.1001/jamanetworkopen.2019.8061.

3.

Public Approval of Exception From Informed Consent in Emergency Clinical Trials: A Systematic Review of Community Consultation Surveys.

Feldman WB, Hey SP, Franklin JM, Kesselheim AS.

JAMA Netw Open. 2019 Jul 3;2(7):e197591. doi: 10.1001/jamanetworkopen.2019.7591.

4.

A concept-wide association study to identify potential risk factors for nonadherence among prevalent users of antihypertensives.

Singh K, Choudhry NK, Krumme AA, McKay C, McElwee NE, Kimura J, Franklin JM.

Pharmacoepidemiol Drug Saf. 2019 Jul 16. doi: 10.1002/pds.4850. [Epub ahead of print]

PMID:
31313427
5.

Impact of State Laws Restricting Opioid Duration on Characteristics of New Opioid Prescriptions.

Dave CV, Patorno E, Franklin JM, Huybrechts K, Sarpatwari A, Kesselheim AS, Bateman BT.

J Gen Intern Med. 2019 Jul 15. doi: 10.1007/s11606-019-05150-z. [Epub ahead of print] No abstract available.

PMID:
31309407
6.

Using Real-World Data to Predict Findings of an Ongoing Phase IV Cardiovascular Outcome Trial: Cardiovascular Safety of Linagliptin Versus Glimepiride.

Patorno E, Schneeweiss S, Gopalakrishnan C, Martin D, Franklin JM.

Diabetes Care. 2019 Jun 25. pii: dc190069. doi: 10.2337/dc19-0069. [Epub ahead of print]

PMID:
31239281
7.

Glucose-lowering medications and the risk of cancer: A methodological review of studies based on real-world data.

Bykov K, He M, Franklin JM, Garry EM, Seeger JD, Patorno E.

Diabetes Obes Metab. 2019 Sep;21(9):2029-2038. doi: 10.1111/dom.13766. Epub 2019 May 29. Review.

PMID:
31062453
8.

Evaluating the use of bootstrapping in cohort studies conducted with 1:1 propensity score matching-A plasmode simulation study.

Desai RJ, Wyss R, Abdia Y, Toh S, Johnson M, Lee H, Karami S, Major JM, Nguyen M, Wang SV, Franklin JM, Gagne JJ.

Pharmacoepidemiol Drug Saf. 2019 Jun;28(6):879-886. doi: 10.1002/pds.4784. Epub 2019 Apr 24.

PMID:
31020732
9.

Empagliflozin and the Risk of Heart Failure Hospitalization in Routine Clinical Care.

Patorno E, Pawar A, Franklin JM, Najafzadeh M, Déruaz-Luyet A, Brodovicz KG, Sambevski S, Bessette LG, Santiago Ortiz AJ, Kulldorff M, Schneeweiss S.

Circulation. 2019 Jun 18;139(25):2822-2830. doi: 10.1161/CIRCULATIONAHA.118.039177. Epub 2019 Apr 8.

PMID:
30955357
10.

Strong triaxial coupling and anomalous Poisson effect in collagen networks.

Ban E, Wang H, Franklin JM, Liphardt JT, Janmey PA, Shenoy VB.

Proc Natl Acad Sci U S A. 2019 Apr 2;116(14):6790-6799. doi: 10.1073/pnas.1815659116. Epub 2019 Mar 20.

PMID:
30894480
11.

A fluorogenic array for temporally unlimited single-molecule tracking.

Ghosh RP, Franklin JM, Draper WE, Shi Q, Beltran B, Spakowitz AJ, Liphardt JT.

Nat Chem Biol. 2019 Apr;15(4):401-409. doi: 10.1038/s41589-019-0241-6. Epub 2019 Mar 11.

PMID:
30858596
12.

Sequential Monitoring of the Comparative Effectiveness and Safety of Dabigatran in Routine Care.

Schneeweiss S, Gopalakrishnan C, Bartels DB, Franklin JM, Zint K, Kulldorff M, Huybrechts KF.

Circ Cardiovasc Qual Outcomes. 2019 Feb;12(2):e005173. doi: 10.1161/CIRCOUTCOMES.118.005173.

PMID:
30764655
13.

Days' Supply of Initial Opioid Analgesic Prescriptions and Additional Fills for Acute Pain Conditions Treated in the Primary Care Setting - United States, 2014.

Mundkur ML, Franklin JM, Abdia Y, Huybrechts KF, Patorno E, Gagne JJ, Meyer TE, Staffa J, Bateman BT.

MMWR Morb Mortal Wkly Rep. 2019 Feb 15;68(6):140-143. doi: 10.15585/mmwr.mm6806a3.

14.

Impact Of The Priority Review Voucher Program On Drug Development For Rare Pediatric Diseases.

Hwang TJ, Bourgeois FT, Franklin JM, Kesselheim AS.

Health Aff (Millwood). 2019 Feb;38(2):313-319. doi: 10.1377/hlthaff.2018.05330.

PMID:
30715972
15.

Evaluation of Socioeconomic Status Indicators for Confounding Adjustment in Observational Studies of Medication Use.

Gopalakrishnan C, Gagne JJ, Sarpatwari A, Dejene SZ, Dutcher SK, Levin R, Franklin JM, Schneeweiss S, Desai RJ.

Clin Pharmacol Ther. 2019 Jun;105(6):1513-1521. doi: 10.1002/cpt.1348. Epub 2019 Feb 25.

PMID:
30659590
16.

Association of Osteoporosis Medication Use After Hip Fracture With Prevention of Subsequent Nonvertebral Fractures: An Instrumental Variable Analysis.

Desai RJ, Mahesri M, Abdia Y, Barberio J, Tong A, Zhang D, Mavros P, Kim SC, Franklin JM.

JAMA Netw Open. 2018 Jul 6;1(3):e180826. doi: 10.1001/jamanetworkopen.2018.0826.

17.

Evaluating the Use of Nonrandomized Real-World Data Analyses for Regulatory Decision Making.

Franklin JM, Glynn RJ, Martin D, Schneeweiss S.

Clin Pharmacol Ther. 2019 Apr;105(4):867-877. doi: 10.1002/cpt.1351. Epub 2019 Feb 25.

PMID:
30636285
18.

Multinomial Extension of Propensity Score Trimming Methods: A Simulation Study.

Yoshida K, Solomon DH, Haneuse S, Kim SC, Patorno E, Tedeschi SK, Lyu H, Franklin JM, Stürmer T, Hernández-Díaz S, Glynn RJ.

Am J Epidemiol. 2019 Mar 1;188(3):609-616. doi: 10.1093/aje/kwy263.

PMID:
30517602
19.

Claims Data Studies of Direct Oral Anticoagulants Can Achieve Balance in Important Clinical Parameters Only Observable in Electronic Health Records.

Huybrechts KF, Gopalakrishnan C, Franklin JM, Zint K, Franca LR, Bartels DB, Landon J, Schneeweiss S.

Clin Pharmacol Ther. 2019 Apr;105(4):979-993. doi: 10.1002/cpt.1256. Epub 2018 Nov 11.

PMID:
30341980
20.

Time to Filling of New Prescriptions for Chronic Disease Medications Among a Cohort of Elderly Patients in the USA.

Franklin JM, Mahesri M, Krumme AA, Barberio J, Fischer MA, Brill G, McKay C, Black H, Choudhry NK.

J Gen Intern Med. 2018 Nov;33(11):1877-1884. doi: 10.1007/s11606-018-4592-6. Epub 2018 Jul 27.

PMID:
30054889
21.

Implications of the Propensity Score Matching Paradox in Pharmacoepidemiology.

Ripollone JE, Huybrechts KF, Rothman KJ, Ferguson RE, Franklin JM.

Am J Epidemiol. 2018 Sep 1;187(9):1951-1961. doi: 10.1093/aje/kwy078.

22.

Predicting Adherence to Chronic Disease Medications in Patients with Long-term Initial Medication Fills Using Indicators of Clinical Events and Health Behaviors.

Lauffenburger JC, Franklin JM, Krumme AA, Shrank WH, Matlin OS, Spettell CM, Brill G, Choudhry NK.

J Manag Care Spec Pharm. 2018 May;24(5):469-477. doi: 10.18553/jmcp.2018.24.5.469.

23.

Efficacy, Safety, and Regulatory Approval of Food and Drug Administration-Designated Breakthrough and Nonbreakthrough Cancer Medicines.

Hwang TJ, Franklin JM, Chen CT, Lauffenburger JC, Gyawali B, Kesselheim AS, Darrow JJ.

J Clin Oncol. 2018 Jun 20;36(18):1805-1812. doi: 10.1200/JCO.2017.77.1592. Epub 2018 Apr 24.

PMID:
29688832
24.

GIFTed Demons: deformable image registration with local structure-preserving regularization using supervoxels for liver applications.

Papież BW, Franklin JM, Heinrich MP, Gleeson FV, Brady M, Schnabel JA.

J Med Imaging (Bellingham). 2018 Apr;5(2):024001. doi: 10.1117/1.JMI.5.2.024001. Epub 2018 Apr 4.

25.

Application and Impact of Run-In Studies for the Evaluation of Statin Efficacy and Safety.

Fralick M, Avorn J, Franklin JM, Bartsch E, Abdurrob A, Kesselheim AS.

J Gen Intern Med. 2018 Jun;33(6):792-794. doi: 10.1007/s11606-018-4349-2. No abstract available.

26.

An evaluation of longitudinal changes in serum uric acid levels and associated risk of cardio-metabolic events and renal function decline in gout.

Desai RJ, Franklin JM, Spoendlin-Allen J, Solomon DH, Danaei G, Kim SC.

PLoS One. 2018 Feb 28;13(2):e0193622. doi: 10.1371/journal.pone.0193622. eCollection 2018.

27.

Application and impact of run-in studies.

Fralick M, Avorn J, Franklin JM, Abdurrob A, Kesselheim AS.

J Gen Intern Med. 2018 May;33(5):759-763. doi: 10.1007/s11606-018-4344-7. Epub 2018 Feb 15.

28.

The relative benefits of claims and electronic health record data for predicting medication adherence trajectory.

Franklin JM, Gopalakrishnan C, Krumme AA, Singh K, Rogers JR, Kimura J, McKay C, McElwee NE, Choudhry NK.

Am Heart J. 2018 Mar;197:153-162. doi: 10.1016/j.ahj.2017.09.019. Epub 2017 Dec 2.

PMID:
29447776
29.

Mechanisms of Plastic Deformation in Collagen Networks Induced by Cellular Forces.

Ban E, Franklin JM, Nam S, Smith LR, Wang H, Wells RG, Chaudhuri O, Liphardt JT, Shenoy VB.

Biophys J. 2018 Jan 23;114(2):450-461. doi: 10.1016/j.bpj.2017.11.3739.

30.

Generalized boosted modeling to identify subgroups where effect of dabigatran versus warfarin may differ: An observational cohort study of patients with atrial fibrillation.

Wang SV, Huybrechts KF, Fischer MA, Franklin JM, Glynn RJ, Schneeweiss S, Gagne JJ.

Pharmacoepidemiol Drug Saf. 2018 Apr;27(4):383-390. doi: 10.1002/pds.4395. Epub 2018 Jan 30.

PMID:
29383858
31.

Collaborative-controlled LASSO for constructing propensity score-based estimators in high-dimensional data.

Ju C, Wyss R, Franklin JM, Schneeweiss S, Häggström J, van der Laan MJ.

Stat Methods Med Res. 2019 Apr;28(4):1044-1063. doi: 10.1177/0962280217744588. Epub 2017 Dec 11.

32.

Claims-based studies of oral glucose-lowering medications can achieve balance in critical clinical variables only observed in electronic health records.

Patorno E, Gopalakrishnan C, Franklin JM, Brodovicz KG, Masso-Gonzalez E, Bartels DB, Liu J, Schneeweiss S.

Diabetes Obes Metab. 2018 Apr;20(4):974-984. doi: 10.1111/dom.13184. Epub 2018 Jan 12.

33.

A Bias in the Evaluation of Bias Comparing Randomized Trials with Nonexperimental Studies.

Franklin JM, Dejene S, Huybrechts KF, Wang SV, Kulldorff M, Rothman KJ.

Epidemiol Methods. 2017 Apr;6(1). pii: 20160018. doi: 10.1515/em-2016-0018. Epub 2017 Apr 22.

34.

Alendronate and Hip Fracture in Patients Using Glucocorticoids.

Desai RJ, Franklin JM, Kim SC.

JAMA. 2017 Nov 7;318(17):1711-1712. doi: 10.1001/jama.2017.14291. No abstract available.

PMID:
29114826
35.

Variation in adherence to medications across the healthcare system in two comparative effectiveness research cohorts.

Franklin JM, Donneyong MM, Desai RJ, Markson L, Girman CJ, McKay C, Patel MD, Mavros P, Schneeweiss S.

J Comp Eff Res. 2017 Oct;6(7):613-625. doi: 10.2217/cer-2016-0095. Epub 2017 Oct 17.

PMID:
29039693
36.

Using Super Learner Prediction Modeling to Improve High-dimensional Propensity Score Estimation.

Wyss R, Schneeweiss S, van der Laan M, Lendle SD, Ju C, Franklin JM.

Epidemiology. 2018 Jan;29(1):96-106. doi: 10.1097/EDE.0000000000000762.

PMID:
28991001
37.

Scalable collaborative targeted learning for high-dimensional data.

Ju C, Gruber S, Lendle SD, Chambaz A, Franklin JM, Wyss R, Schneeweiss S, van der Laan MJ.

Stat Methods Med Res. 2019 Feb;28(2):532-554. doi: 10.1177/0962280217729845. Epub 2017 Sep 22.

38.

When and How Can Real World Data Analyses Substitute for Randomized Controlled Trials?

Franklin JM, Schneeweiss S.

Clin Pharmacol Ther. 2017 Dec;102(6):924-933. doi: 10.1002/cpt.857. Epub 2017 Sep 25.

PMID:
28836267
39.

ATSAS 2.8: a comprehensive data analysis suite for small-angle scattering from macromolecular solutions.

Franke D, Petoukhov MV, Konarev PV, Panjkovich A, Tuukkanen A, Mertens HDT, Kikhney AG, Hajizadeh NR, Franklin JM, Jeffries CM, Svergun DI.

J Appl Crystallogr. 2017 Jun 26;50(Pt 4):1212-1225. doi: 10.1107/S1600576717007786. eCollection 2017 Aug 1.

40.

Association of the Priority Review Voucher With Neglected Tropical Disease Drug and Vaccine Development.

Jain N, Hwang T, Franklin JM, Kesselheim AS.

JAMA. 2017 Jul 25;318(4):388-389. doi: 10.1001/jama.2017.7467. No abstract available.

41.

Success, Failure, and Transparency in Biomarker-Based Drug Development: A Case Study of Cholesteryl Ester Transfer Protein Inhibitors.

Hey SP, Franklin JM, Avorn J, Kesselheim AS.

Circ Cardiovasc Qual Outcomes. 2017 Jun;10(6). pii: e003121. doi: 10.1161/CIRCOUTCOMES.116.003121. Review.

PMID:
28611186
42.

Drug safety analyses in a rheumatoid arthritis registry: application of different approaches regarding timing of exposure and confounder measurement.

Solomon DH, Shadick NA, Weinblatt ME, Zak A, Frits M, Franklin JM.

Arthritis Res Ther. 2017 Jun 13;19(1):130. doi: 10.1186/s13075-017-1330-0.

43.

Metabolic nodal response as a prognostic marker after neoadjuvant therapy for oesophageal cancer.

Findlay JM, Bradley KM, Wang LM, Franklin JM, Teoh EJ, Gleeson FV, Maynard ND, Gillies RS, Middleton MR.

Br J Surg. 2017 Jun;104(7):947. doi: 10.1002/bjs.10611. No abstract available.

PMID:
28518409
44.

Patient-Centered Medical Homes and Adherence to Chronic Disease Medications.

Lauffenburger JC, Franklin JM, Choudhry NK.

Ann Intern Med. 2017 May 16;166(10):761-762. doi: 10.7326/L17-0158. No abstract available.

PMID:
28505651
45.

Predictors of emergency department use in children with persistent asthma in metropolitan Atlanta, Georgia.

Franklin JM, Grunwell JR, Bruce AC, Smith RC, Fitzpatrick AM.

Ann Allergy Asthma Immunol. 2017 Aug;119(2):129-136. doi: 10.1016/j.anai.2017.04.008. Epub 2017 May 4.

46.

Patterns and predictors of persistent opioid use following hip or knee arthroplasty.

Kim SC, Choudhry N, Franklin JM, Bykov K, Eikermann M, Lii J, Fischer MA, Bateman BT.

Osteoarthritis Cartilage. 2017 Sep;25(9):1399-1406. doi: 10.1016/j.joca.2017.04.002. Epub 2017 Apr 19.

47.

Assessment of Confounders in Comparative Effectiveness Studies From Secondary Databases.

Franklin JM, Schneeweiss S, Solomon DH.

Am J Epidemiol. 2017 Mar 15;185(6):474-478. doi: 10.1093/aje/kww136.

PMID:
28399570
48.

Effects of expanding the look-back period to all available data in the assessment of covariates.

Nakasian SS, Rassen JA, Franklin JM.

Pharmacoepidemiol Drug Saf. 2017 Aug;26(8):890-899. doi: 10.1002/pds.4210. Epub 2017 Apr 11.

PMID:
28397352
49.

Effect of US Food and Drug Administration's Cardiovascular Safety Guidance on Diabetes Drug Development.

Hwang TJ, Franklin JM, Kesselheim AS.

Clin Pharmacol Ther. 2017 Aug;102(2):290-296. doi: 10.1002/cpt.705. Epub 2017 May 27. Review.

PMID:
28390139
50.

The effect of federal and state off-label marketing investigations on drug prescribing: The case of olanzapine.

Wang B, Studdert DM, Sarpatwari A, Franklin JM, Landon J, Kesselheim AS.

PLoS One. 2017 Apr 7;12(4):e0175313. doi: 10.1371/journal.pone.0175313. eCollection 2017.

Supplemental Content

Loading ...
Support Center